At the same time, we collected clinical indicators (such as fever, cough, WBC, IL-6, CRP), performed Spearman correlation analysis on clinical indicators and differential metabolites, and finally studied the diagnostic biomarkers and possible potential pathogenesis of patients with COVID-19 through metabolomics. This evidence concerns the gene IL6 and COVID-19.